Skip to main content
. Author manuscript; available in PMC: 2010 Sep 22.
Published in final edited form as: Transplant Proc. 1987 Apr;19(2 Suppl 1):37–44.

Table 3.

Comparison of Allograft and Patient Survival Between Orthoclone OKT3-Treated and Control Groups

Group Allograft Survival (%)
 Patient Survival (%)
6 mo 1 yr 6 mo 1 yr
Control 63.4 55.0 73.7 71.6
Orthoclone OKT3-treated
 Overall 72.4 (P < .003) 64.4 (P < .01) 82.9 (P < .01) 75.2 (NS)
 Group 1 54.1 (NS) 54.1 (NS) 72.1 (NS) 67.1 (NS)
 Group 2 80.7 (P < .003) 76.7 (P < .003) 86.7 (P < .005) 79.2 (NS)
 Group 3 68.8 (P < .05) 44.5 (NS) 81.2 (NS) 72.2 (NS)

Statistical comparison between patients with evidence of rejection treated with Orthoclone OKT3 and control patients. NS indicates that P > .05.